Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
View the BMRN historical prices.
The 52 Week Low is $76.02 set on Mon, Nov 6, 2023.
The 52 Week High is $100.38 set on Mon, Apr 17, 2023. The current price, $87.34, is 0% below the 52 Week High.
The All-Time High is $151.75 set on Mon, Jul 20, 2015. The current price, $87.34, is 0% below the All Time High.
BMRN has no dividend history.
Annual Dividend Yield
Quarterly Dividend Rate
Declaration Date
Ex-Dividend Date
Record Date
Payment Date
Dividend Frequency
Dividend History
BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU. Voxzogo (vosoritide) was approved in achondroplasia in 2021. BioMarin's Roctavian (hemophilia A gene therapy) was approved in Europe in 2022 and in the US in 2023.
Did you know you can earn $30 back on your first $30 of qualifying purchases with Rakuten?
Join now and start saving on every purchase from top retailers like Target, eBay, Zappos, Walmart, Kohl's & CVS. Whether you're shopping for fashion, electronics, home essentials, or health products, Rakuten makes it rewarding.
Sign up through this link and explore the endless possibilities to save and earn cash back!
Check out the Symbol Surfing blog to learn about investing.